AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19
Clinical trial NCT04507256 · COMPLETED
Trial details
- NCT number
- NCT04507256
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-18
- Primary completion
- 2021-10-19
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.